Montpellier Méditerranée Métropole is a rich wine-growing region, with over 200 winegrowers and about 3,000 hectares of vineyards. Just like Bordeaux and Macon, Montpellier once again aspires to become a French capital for wine.

The business exchange program was originally set up by the two cities’ economic development departments for local businesses, but has now been expanded with customizable export programs.

Thirty students at the Les Garrigues middle school in Montpellier’s La Mosson district met with 5 Montpellier BIC companies as part of the Science Explorers program. This original idea is intended to help them learn about entrepreneurship.

Mathematic, a special effects production and animation studio expands its global presence with its facility in Montpellier. Their decision to set up operations here supports Cité Créative vitality in a fast-growing CCI district.

Seeking to directly support entrepreneurship for women, France Active Airdie-Occitanie undertook a specific action: Les Essenti’Elles. This custom program is designed to provide assistance for women in Montpellier’s underprivileged neighborhoods.

The first Employer Mobility Plan (PDME) for Montpellier’s Hospital-University/Agropolis area was held on March 31 at the CNRS site. 13 public and private employers representing over 25,000 agents and employees attended.

Since February, the Montpellier-based company PimpUp has been offering fresh, seasonal fruits and vegetables that producers were unable to sell. The baskets are prepared at Croix Rouge Insertion by people currently in vocational transition.

SIMI 2022 came to a close, once again a wonderful event that enabled teams from Montpellier Méditerranée Métropole, SERM/SA3M Group, and our partners to help Montpellier stand out from the crowd!

Every year, Les Hivernales welcomes the Montpellier Christmas market. Artisans and merchants come to meet Montpellier area residents with an eco-responsible event. Take a look behind the scenes with our new podcast!

MedinCell and its partner TEVA announced that US FDA approuved UZEDY™, a long-acting injectable medication for treating schizophrenia. MedinCell also raised 25 million euros.